Keefe Bruyette analyst Paul Johnson downgraded Blue Owl Capital to Market Perform from Outperform with an unchanged price target of $16. Shares have performed “very strongly,” rising 45% over the last year and 15% year-to-date, notes the analyst, who is reducing 2024 estimates and believes upside is limited from current levels.